OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,650 | -57.9% | 22,500 | -30.8% | 0.01% | -57.9% |
| Q2 2023 | $167,700 | -84.7% | 32,500 | -84.3% | 0.02% | -86.0% |
| Q1 2023 | $1,094,178 | +43.8% | 207,624 | -23.3% | 0.14% | +33.3% |
| Q4 2022 | $760,645 | -49.6% | 270,692 | -25.6% | 0.10% | -50.2% |
| Q3 2022 | $1,510,000 | +183.3% | 363,844 | +174.3% | 0.20% | +225.4% |
| Q2 2022 | $533,000 | -13.2% | 132,654 | +80.0% | 0.06% | -25.0% |
| Q2 2020 | $614,000 | +314.9% | 73,678 | +145.6% | 0.08% | +250.0% |
| Q1 2020 | $148,000 | -16.9% | 30,000 | -33.3% | 0.02% | +33.3% |
| Q4 2019 | $178,000 | – | 45,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |